Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/2/2026

Maximum Intravenous Paracetamol Dosing in Adults

  • The maximum recommended intravenous paracetamol dose for adults is 4 g per 24 hours, administered as 1 g every 4–6 hours or 15 mg/kg every 6–8 hours (maximum 1 g per dose). [1][2]3

Weight‑Based Dosing

  • Adults ≥ 50 kg: give 1 g per dose every 4–6 hours. 1
  • Adults < 50 kg: give 15 mg/kg per dose every 6–8 hours. 1

Loading Dose

  • A standard loading dose of 15–20 mg/kg (typically 1 g in adults ≥ 50 kg) is recommended. 1

Safety Considerations

Hepatotoxicity

  • The FDA issues a boxed warning that acetaminophen overdose can cause severe liver injury, liver failure, and death. [2][3]
  • For chronic administration, limit the total daily dose to ≤ 3 g to reduce hepatotoxic risk. [2][3]
  • In patients with cirrhosis or chronic liver disease, limit the total daily dose to 2–3 g. 4
  • Use extreme caution with opioid‑acetaminophen combination products to prevent inadvertent overdosing. [5][2]3

Special Populations

  • Elderly patients: maintain the 4 g per day limit, but some guidelines suggest reducing to 3 g for chronic use. 6
  • Renal impairment: extend dosing intervals to at least every 8 hours. 1

Practical Dosing Intervals

  • Minimum interval: every 4 hours for adults ≥ 50 kg. [1][7]
  • Standard interval: every 6 hours (most commonly recommended). [1][8][9][10]
  • Extended interval: every 8 hours in renal impairment or when combined with other analgesics. 1

Common Pitfalls to Avoid

  • Account for all sources of acetaminophen—including over‑the‑counter and combination products—to avoid exceeding the maximum daily dose. [5][2]
  • Do not add oral or rectal acetaminophen concurrently without adjusting the total daily dose. 1
  • Patients with any degree of liver disease require dose reduction and careful monitoring. [4][8][9][10]

Paracetamol Dosage Recommendations and Safety Evidence

Adult Maximum Dose

Elderly Considerations

Renal Impairment

Hepatotoxicity Risk

Chronic Use Risks

REFERENCES

2

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

3

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

5

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2013

6

pharmacological management of persistent pain in older persons. [LINK]

Journal of the American Geriatrics Society (JAGS), 2009